by Richard Daverman, PhD
December 12, 2013 -- Consun Pharmaceutical Group, a Guangzhou TCM and drug maker, will stage an IPO on the Hong Kong Exchange, raising up to $141 million. The deal will be priced on December 13 and begin trading on December 19. The company will offer 250 million shares. During the first half of 2013, Consun generated $37.2 million in revenues and net income of $9.7 million. More details....
Help employers find you! Check out all the jobs and post your resume.
